ASX:CUV (Australia)  
Clinuvel Pharmaceuticals Ltd logo

Clinuvel Pharmaceuticals Ltd

A$ 18.23 (+3.23%) Sep 29
P/E:
45.23
P/B:
7.17
Market Cap:
A$ 900.75M ($ 585.14M)
Enterprise V:
A$ 780.50M ($ 507.02M)
Volume:
153.06K
Avg Vol (2M):
194.84K
Also Trade In:
Volume:
153.06K
Market Cap A$:
900.75M
Market Cap $:
585.14M
PE Ratio:
45.23
Avg Vol (2-Month):
194.84K
Enterprise Value A$:
780.50M
Enterprise Value $:
507.02M
PB Ratio:
7.17
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Clinuvel Pharmaceuticals Ltd is an Australia-based biopharmaceutical company. It is engaged in developing drugs for the treatment of genetic and vascular disorders. Its principal compound, SCENESSE is a drug for erythropoietic protoporphyria. Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to harmful UV radiation and at repigmentation of the skin due to several depigmentation disorders. Geographically, it derives a majority of its revenue from Europe and the USA.

Financials

ASX:CUV's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 65.722
EPS (TTM) (A$) 0.403
Beta 0.53
Volatility % 48.16
14-Day RSI 44.12
14-Day ATR (A$) 1.177682
20-Day SMA (A$) 19.7815
12-1 Month Momentum % -58.14
52-Week Range (A$) 13.16 - 42.86
Shares Outstanding (Mil) 49.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clinuvel Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data

Clinuvel Pharmaceuticals Ltd Analysis

Share your research